Results 121 to 130 of about 3,549 (185)

Aortitis after granulocyte-colony stimulating factor administration: A case report. [PDF]

Biomed Rep
Fujiwara S, Hara H, Fukase N, Sawada R, Takemori T, Miyamoto T, Nakamatsu Y, Kuroda R, Akisue T.   +8 more
europepmc   +1 more source

Risks of haematological malignancies in patients treated for solid tumours associated with the use of pegylated granulocyte colony-stimulating factors: A single centre study since 2005. [PDF]

Oncol Lett
Vokurka S, Mastný L, Kliment V, Kulhánková J, Dreslerová J, Šamanová T, Fínek J.   +6 more
europepmc   +1 more source

A Rare Presentation of Alveolar Rhabdomyosarcoma of the Sinonasal and Nasopharyngeal Region With Bone Marrow Metastasis. [PDF]

Cureus
Al Tatari M, Ramirez J, Hernandez S, Martinez E, Casadesus D.   +4 more
europepmc   +1 more source

Analysis of remobilization efficiency of etoposide combined with cytarabine and pegfilgrastim, with or without plerixafor, for multiple myeloma recurrence following autologous hematopoietic stem cell transplantation. [PDF]

Clin Exp Med
Zhou Y, Qian H, Zheng J, Lu Y, Ye P.
europepmc   +1 more source

Biologic Drug Prices in Medicare Part B After Entry of Biosimilars to the Market.

JAMA Netw Open
Abdelaziz A, Winn AN, Dusetzina SB, Mitchell AP.   +3 more
europepmc   +1 more source

Long-acting lipegfilgrastim and antimicrobials as vigorous primary prophylaxis in bendamustine-treated patients with indolent B cell non-Hodgkin lymphoma: a multicentric real-life experience. [PDF]

Support Care Cancer
Giordano C, Picardi M, Vincenzi A, Scarpa A, Lombardi A, Carchia M, Damiano V, Bianco R, Trastulli F, Ronconi F, Annunziata M, Pane F.   +11 more
europepmc   +1 more source

Sacituzumab-induced severe or febrile neutropenia and G-CSF utilization and cost for advanced HER2-negative breast cancer: a single-center retrospective analysis. [PDF]

Breast Cancer Res Treat
Tam G, Waddell D, Freeman JQ, Chen N, Yang H.   +4 more
europepmc   +1 more source

Comparative efficacy and safety of individual short-acting versus long-acting granulocyte colony-stimulating factors, including biosimilars, for primary prophylaxis of chemotherapy-induced myelosuppression in breast cancer patients: a systematic review and network meta-analysis protocol. [PDF]

Front Oncol
Bi X, Shu S, Tang K, Yin P, Chen Y.
europepmc   +1 more source

Granulocyte colony-stimulating factor-associated aortitis in a man with advanced prostate cancer. [PDF]

IJU Case Rep
Ikadai R, Kitano G, Kato M, Kojima T.
europepmc   +1 more source

Literature review analysis of aortitis induced by granulocyte-colony stimulating factor. [PDF]

Front Pharmacol
Zhao T, Xu H.
europepmc   +1 more source